Fiche publication
Date publication
mars 2026
Journal
Journal of Crohn's & colitis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Moreira PL, Dignass A, Estevinho MM, Santiago M, Reinisch W, Sands BE, D'Haens G, Mantzaris GJ, Danese S, Peyrin-Biroulet L, Dotan I, Jairath V, Magro F,
Lien Pubmed
Résumé
Real-world evidence (RWE) studies complement randomized trials by assessing treatment effectiveness and safety in routine clinical practice. In Crohn's disease (CD), heterogeneous disease progression makes standardized timing of outcome assessment critical, yet guidance is limited.
Mots clés
Crohn’s disease, inflammatory bowel disease, outcome measurement, real-world evidence, timing of assessment
Référence
J Crohns Colitis. 2026 03 10;20(3):
